Content about New Drugs & OTCs

January 25, 2013
Wellco Brands launches pain relief cream for under the nose of cold, allergy sufferers

Wellco Brands on Thursday launched Healerz for Noses, a pain relief cream to soothe the skin under the nose that becomes irritated during cold and allergy season.

January 24, 2013
Perrigo, Ther-Rx announce availability of Gynazole-1

Perrigo and a subsidiary of K-V Pharmaceutical Co. have launched a new drug for yeast infections in women, the two companies said.

January 23, 2013
FDA approves Novartis drug for rare blood disorder

The Food and Drug Administration has approved a new drug for removing excess iron from the blood in patients with a rare genetic disorder, the agency said.

January 22, 2013
FDA approves Lupin contraceptive

The Food and Drug Administration has approved a generic contraceptive made by Lupin Pharmaceuticals, the drug maker said Tuesday.

January 18, 2013
STS Health launches FluNada nasal spray

STS Health announced the launch of its homeopathic cold and flu symptom reliever FluNada.

January 16, 2013
Evenup device offers 'lift' to patients wearing a fracture boot

The slight discrepancy in leg length while wearing a fracture boot can cause patients pain and discomfort. The removable, reusable and adjustable Evenup shoelift equalizes the induced limb-length discrepancy caused by fracture walkers, cast boots or thick-soled wound healing shoes.

January 16, 2013
Giffen releases STD-prevention app

A new app allows people to share their STD statuses with potential partners.

January 14, 2013
Pfizer announces availability of new ADHD drug

A new drug for treating attention deficit hyperactivity disorder made by Pfizer is now available, the drug maker said.

January 11, 2013
Ferndale Healthcare launches new site

Ferndale Healthcare unveiled a redesigned corporate web site Ferndalehealthcare.com to make it easier for a variety of target audiences to navigate the site.

January 10, 2013
FDA approves Bayer IUD

The Food and Drug Administration has approved a new intrauterine device for preventing pregnancy made by Bayer HealthCare Pharmaceuticals, the drug maker said.

January 10, 2013
FDA approves Wockhardt epilepsy drug

The Food and Drug Administration has approved a generic epilepsy drug made by Wockhardt, the company said.

January 10, 2013
Medela launches Calma breastmilk feeding system into mass, specialty

The Calma breastmilk feeding system from Medela, which helps emulate the breastfeeding experience for babies, is now available in major national retail stores, Medela announced Thursday.

January 8, 2013
iHealth Labs launches two new Apple-compatible diagnostic devices at Consumer Electronics Show

iHealth Labs on Monday unveiled two new additions to its suite of devices — the iHealth Wireless Smart Gluco-Monitoring System and iHealth Pulse Oximeter — at the 2013 Consumer Electronics Show in Las Vegas.

January 7, 2013
Prasco launches authorized generic version of Lysteda

Drug maker Prasco Labs has launched an authorized generic version of a drug used to treat heavy menstrual bleeding, the company said.

January 7, 2013
Retail Clinician Education Congress seeks posts for Sixth Annual RCEC

You're invited to submit a post for the Sixth Annual Retail Clinician Education Congress. The Retail Clinician Education Congress will be featuring CE break-out sessions and panel discussions on topics submitted by retail clinicians and organizations.

January 3, 2013
Dr. Reddy's launches hair-loss drug

Dr. Reddy's Labs has launched a generic drug for treating baldness, the Indian drug maker said.

January 3, 2013
Greenstone launches authorized generic Dilantin Infatabs

Pfizer's generics division has launched an authorized generic drug for treating epilepsy.

January 3, 2013
Par ships migraine drug

Par Pharmaceutical Cos. has started shipping two formulations of a generic drug for treating migraines, the company said.

January 3, 2013
Teva announces inhaler with dose counter for bronchospasm

An inhaler for patients with bronchospasm that includes a dose counter has become available from Teva Respiratory, the company said Thursday.

January 2, 2013
FDA approves Bristol-Myers Squibb's Eliquis to reduce risk of stroke, blood clots

The Food and Drug Administration last week approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. Eliquis is manufactured by Bristol-Myers Squibb, and marketed by BMS and Pfizer.

January 2, 2013
FDA approves Mylan's generic Maxalt MLT tablet

Mylan announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for rizatriptan benzoate orally disintegrating tablets and rizatriptan benzoate tablets, generic versions of Merck's Maxalt MLT Tablets and Maxalt Tablets.

January 2, 2013
First anti-diarrheal drug for HIV/AIDS patients receives FDA approval

The U.S. Food and Drug Administration on Monday approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.

December 28, 2012
FDA approves Mylan's generic Dilantin chewable tablets

Mylan on Friday announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its phenytoin chewable tablets USP in the 50 mg strength.

December 28, 2012
Watson confirms Velcade patent challenge

Watson Pharmaceuticals on Friday confirmed that Actavis, which was acquired by Watson in October, has filed an abbreviated new drug applications with the Food and Drug Administration seeking approval to market bortezomib, a generic version of Millennium Pharmaceuticals' Velcade.

December 27, 2012
Aegerion receives FDA approval for cholesterol drug, with strongest warning

The Food and Drug Administration on Monday approved Aegerion Pharmaceuticals' cholesterol drug, Juxtapid.

© 2013 Drug Store News. All Rights Reserved.